Jayaprakasam Bolleddula, Sathej Gopalakrishnan, Ping Hu, Jennifer Dong, & Karthik Venkatakrishnan. (2022). Alternatives to rifampicin: A review and perspectives on the choice of strong CYP3A inducers for clinical drug-drug interaction studies. Wiley.
Chicago Style (17th ed.) CitationJayaprakasam Bolleddula, Sathej Gopalakrishnan, Ping Hu, Jennifer Dong, and Karthik Venkatakrishnan. Alternatives to Rifampicin: A Review and Perspectives on the Choice of Strong CYP3A Inducers for Clinical Drug-drug Interaction Studies. Wiley, 2022.
MLA (9th ed.) CitationJayaprakasam Bolleddula, et al. Alternatives to Rifampicin: A Review and Perspectives on the Choice of Strong CYP3A Inducers for Clinical Drug-drug Interaction Studies. Wiley, 2022.
Warning: These citations may not always be 100% accurate.